Skip to main content

Table 1 The clinicopathologic features

From: The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer

Index

n (%)

Age

 

 < 60

83 (70.94)

 ≥ 60

34 (29.06)

Pathology

 

 Squamous cell carcinoma

97 (81.91)

 Adenocarcinoma

20 (17.09)

FIGO stage

 

 IIA

26 (22.22)

 IIB

62 (52.99)

 IIIA

8 (6.84)

 IIIB

16 (13.68)

 IIIC

5 (4.27)

Radiation technique

 

 IMRT

29 (24.79)

 VMAT

88 (75.21)

KPS score

 

 80–90

57 (48.72)

 > 90

60 (51.28)

Induction chemotherapy

 

 Yes

92 (78.63)

 No

25 (21.37)

Concurrent chemotherapy circles

 

 3–4 circles

66 (56.41)

 5 circles

51 (43.59)

Lymphocytotoxicity

 

 0

6 (5.12)

 1–4

111 (94.88)

 3–4

80 (68.38)

  1. FIGO Federation International Of Gynecology And Obstetrics, IMRT intensity-modulated radiation therapy, VMAT volume-modulated arc therapy, KPS Karnofsky Performance Status